-

MDClone Named “Best Healthcare Big Data Platform” in 2021 MedTech Breakthrough Awards Program

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

BE'ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a leading healthcare data analytics company, today announced that its MDClone ADAMS Platform was selected as the winner of the “Best Healthcare Big Data Platform” Award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

MDClone developed the first-of-its-kind big data platform enabling healthcare organizations to dynamically and securely access, organize and share patient data across the entire ecosystem instantly, without mediators. The MDClone ADAMS Platform leverages massive data assets into operational, research and innovation-oriented insights and actions that impact patient health.

At its core, the solution is a healthcare-oriented data lake with query, discovery and collaboration tools, which, together with MDClone's Synthetic Data Engine, create a unique and powerful solution democratizing data across healthcare organizations. The flexibility of the MDClone ADAMS Platform allows users to view any subpopulation of interest and to focus on each patient's unique, longitudinal timeline of clinical encounters and events.

“MDClone’s ADAMS Platform provides a breakthrough self-service, secure environment that researchers, clinicians and leadership need in order to ask questions and find the answers that matter, at a pace that makes a real difference for healthcare,” said James Johnson, Managing Director, MedTech Breakthrough. “We extend our congratulations to MDClone for their innovative big-data platform that allows institutions around the world to better understand the health of their patients and to develop solutions for care delivery.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories. This year’s program attracted more than 3,850 nominations from over 17 different countries throughout the world.

“Siloed systems and teams, slow processes, IRB approvals, regulations, long timelines and lack of support have led to an over-mediated and antiquated data analysis and extraction process that is long overdue for modernization,” said Ziv Ofek, Founder and CEO, MDClone. “We are honored to be recognized by MedTech Breakthrough for our innovative technology that not only tackles many challenges faced by the healthcare industry, but also helps healthcare workers improve patient outcomes by allowing them to see true relationships within their massive amounts of healthcare data to help inform diagnosis and treatment options.”

To learn more about how MDClone and the MDClone ADAMS Platform can positively impact clinical care and health-organization revenue, visit mdclone.com.

About MDClone

MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout the healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel. For more information, visit mdclone.com.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Contacts

Erin Giegling
Director of Strategic Marketing
erin.giegling@mdclone.com

MDClone


Release Summary
MDClone ADAMS Platform was selected as the winner of the “Best Healthcare Big Data Platform” Award in the annual MedTech Breakthrough Awards program.
Release Versions

Contacts

Erin Giegling
Director of Strategic Marketing
erin.giegling@mdclone.com

More News From MDClone

MDClone Launches the Only Synthetic Data Platform for Life Science RWE Project Collaboration

BE'ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a digital health company and the leader in synthetic data, today announced the launch of The MDClone Connect Platform, an innovative workspace enabling cross-organizational collaboration with dynamic access to 50+ million synthetic patient records. Uniting life sciences, tech companies, and other third-party organizations with leading health systems worldwide, the Connect Platform will allow users to securely and efficiently work together on projec...

MDClone Wins Second Consecutive “Best Healthcare Big Data Platform” Award in Annual MedTech Breakthrough Awards Program

BE’ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a leading data analytics and synthetic data company, today announced that for the second year in a row, the MDClone ADAMS Platform has been recognized as the “Best Healthcare Big Data Platform” in the annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market. At the core...

MDClone Raises $63 Million in Series C Funding to Fuel Global Growth

BE’ER SHEVA, Israel--(BUSINESS WIRE)--MDClone, a digital health company, today announced a $63 million Series C round of funding, led by two new investors Warburg Pincus, a leading global growth investor, and Viola Growth, Israel’s leading growth fund, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed. MDClone provides clinicians and healthcare professionals with the ability to explore healthcare data independently and without barriers. The MDClone ADAMS...
Back to Newsroom